Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Clinical Trial

Anti-Neuroinflammatory Properties of n-3 Fatty Acids and Nano- Curcumin on Migraine Patients from Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial

Author(s): Niyaz M. Honarvar, Neda Soveid, Mina Abdolahi, Mahmoud Djalali, Mahsa Hatami* and Nazanin H. Karzar

Volume 21, Issue 2, 2021

Published on: 29 July, 2020

Page: [365 - 373] Pages: 9

DOI: 10.2174/1871530320666200729144430

Price: $65

Abstract

Background and Objectives: Migraine is an exhausting neuro-inflammatory disorder recognized as recurrent headache attacks. Evidence has shown that Interleukin (IL)-1β plays a substantial role in the neuro-immunity pathogenicity of migraine. n-3 fatty acids and curcumin revealed neuromodulatory and anti-inflammatory effects through several pathways, of which the suppression of IL-1β gene expression is an important inflammatory pathway. The aim of this study was the investigation of synergistic relation of n -3 fatty acids and nano-curcumin on IL-1β gene expression and serum levels in migraine patients.

Methods: This study was performed as a randomized, double-blind, placebo-controlled trial in a period of two months. A total of 80 episodic migraines were assigned into 4 groups of 1) n-3 fatty acids and curcumin combination; 2) n -3 fatty acids; 3) nano-curcumin; and 4) n-3 fatty acids and curcumin placebo. The gene expression and serum level of IL-1β were measured by real-time PCR and ELISA methods respectively, at the beginning and the end of the interventions.

Results: Results showed the n-3 fatty acids and nano-curcumin combination significantly reduced the attack frequency in a synergistic status (P < 0.001). A significantly greater reduction in the serum level of IL-1β was observed in the combination group, and the differences in the other groups were not statistically significant. The IL-1β gene expression in the combination group showed a significant reduction for other treatment groups (P < 0.05), but these significant differences were absent after multiple testing Bonferroni corrections.

Conclusion: Present findings revealed that n -3 fatty acids and curcumin co-supplementation can be suggested as a promising new approach in migraine headache management, but further studies are needed to confirm these findings.

Keywords: Migraine, nano-curcumin, n-3 fatty acids, IL-1β, gene expression, randomized clinical trial.

« Previous Next »
Graphical Abstract

[1]
Uzar, E.; Evliyaoglu, O.; Yucel, Y.; Ugur Cevik, M.; Acar, A.; Guzel, I.; Islamoglu, Y.; Colpan, L.; Tasdemir, N. Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine. Eur. Rev. Med. Pharmacol. Sci., 2011, 15(10), 1111-1116.
[PMID: 22165670]
[2]
Goadsby, P.J.; Charbit, A.R.; Andreou, A.P.; Akerman, S.; Holland, P.R. Neurobiology of migraine. Neuroscience, 2009, 161(2), 327-341.
[http://dx.doi.org/10.1016/j.neuroscience.2009.03.019] [PMID: 19303917]
[3]
Sarchielli, P.; Alberti, A.; Baldi, A.; Coppola, F.; Rossi, C.; Pierguidi, L.; Floridi, A.; Calabresi, P. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache, 2006, 46(2), 200-207.
[http://dx.doi.org/10.1111/j.1526-4610.2006.00337.x] [PMID: 16492228]
[4]
Yilmaz, I.A.; Özge, A.; Erdal, M.E.; Edgünlü, T.G.; Çakmak, S.E.; Yalin, O.Ö. Cytokine polymorphism in patients with migraine: some suggestive clues of migraine and inflammation. Pain Med., 2010, 11(4), 492-497.
[http://dx.doi.org/10.1111/j.1526-4637.2009.00791.x] [PMID: 20113413]
[5]
Binshtok, A.M.; Wang, H.; Zimmermann, K.; Amaya, F.; Vardeh, D.; Shi, L.; Brenner, G.J.; Ji, R.R.; Bean, B.P.; Woolf, C.J.; Samad, T.A. Nociceptors are interleukin-1β sensors. J. Neurosci., 2008, 28(52), 14062-14073.
[http://dx.doi.org/10.1523/JNEUROSCI.3795-08.2008] [PMID: 19109489]
[6]
Zhang, X.; Burstein, R.; Levy, D. Local action of the proinflammatory cytokines IL-1β and IL-6 on intracranial meningeal nociceptors. Cephalalgia, 2012, 32(1), 66-72.
[http://dx.doi.org/10.1177/0333102411430848] [PMID: 22144718]
[7]
Saw, C.L.L.; Huang, Y.; Kong, A-N. Synergistic anti-inflammatory effects of low doses of curcumin in combination with polyunsaturated fatty acids: docosahexaenoic acid or eicosapentaenoic acid. Biochem. Pharmacol., 2010, 79(3), 421-430.
[http://dx.doi.org/10.1016/j.bcp.2009.08.030] [PMID: 19744468]
[8]
Moon, D-O.; Kim, M-O.; Choi, Y.H.; Park, Y-M.; Kim, G-Y. Curcumin attenuates inflammatory response in IL-1β-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. Int. Immunopharmacol., 2010, 10(5), 605-610.
[http://dx.doi.org/10.1016/j.intimp.2010.02.011] [PMID: 20188213]
[9]
Ramsden, C.E.; Faurot, K.R.; Zamora, D.; Suchindran, C.M.; Macintosh, B.A.; Gaylord, S.; Ringel, A.; Hibbeln, J.R.; Feldstein, A.E.; Mori, T.A.; Barden, A.; Lynch, C.; Coble, R.; Mas, E.; Palsson, O.; Barrow, D.A.; Mann, J.D. Targeted alteration of dietary n-3 and n-6 fatty acids for the treatment of chronic headaches: a randomized trial. Pain, 2013, 154(11), 2441-2451.
[http://dx.doi.org/10.1016/j.pain.2013.07.028] [PMID: 23886520]
[10]
Esserlind, A.L.; Christensen, A.F.; Le, H.; Kirchmann, M.; Hauge, A.W.; Toyserkani, N.M.; Hansen, T.; Grarup, N.; Werge, T.; Steinberg, S.; Bettella, F.; Stefansson, H.; Olesen, J. Replication and meta-analysis of common variants identifies a genome-wide significant locus in migraine. Eur. J. Neurol., 2013, 20(5), 765-772.
[http://dx.doi.org/10.1111/ene.12055] [PMID: 23294458]
[11]
Rangel-Huerta, O.D.; Aguilera, C.M.; Mesa, M.D.; Gil, A. Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br. J. Nutr., 2012, 107(S2)(Suppl. 2), S159-S170.
[http://dx.doi.org/10.1017/S0007114512001559] [PMID: 22591890]
[12]
Harel, Z.; Gascon, G.; Riggs, S.; Vaz, R.; Brown, W.; Exil, G. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J. Adolesc. Health, 2002, 31(2), 154-161.
[http://dx.doi.org/10.1016/S1054-139X(02)00349-X] [PMID: 12127385]
[13]
Zaky, A.; Mahmoud, M.; Awad, D.; El Sabaa, B.M.; Kandeel, K.M.; Bassiouny, A.R. Valproic acid potentiates curcumin-mediated neuroprotection in lipopolysaccharide induced rats. Front. Cell. Neurosci., 2014, 8(337), 337.
[http://dx.doi.org/10.3389/fncel.2014.00337] [PMID: 25374508]
[14]
Klawitter, M.; Quero, L.; Klasen, J.; Gloess, A.N.; Klopprogge, B.; Hausmann, O.; Boos, N.; Wuertz, K. Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity. J. Inflamm. (Lond.), 2012, 9(1), 29.
[http://dx.doi.org/10.1186/1476-9255-9-29] [PMID: 22909087]
[15]
Yan, Y.; Jiang, W.; Spinetti, T.; Tardivel, A.; Castillo, R.; Bourquin, C.; Guarda, G.; Tian, Z.; Tschopp, J.; Zhou, R. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity, 2013, 38(6), 1154-1163.
[http://dx.doi.org/10.1016/j.immuni.2013.05.015] [PMID: 23809162]
[16]
Ward, T.N. Migraine diagnosis and pathophysiology. Continuum (Minneap. Minn.), 2012, 18(4), 753-763.
[http://dx.doi.org/10.1212/01.CON.0000418640.07405.31] [PMID: 22868539]
[17]
Garza, I.; Swanson, J.W. Prophylaxis of migraine. Neuropsychiatr. Dis. Treat., 2006, 2(3), 281-291.
[http://dx.doi.org/10.2147/nedt.2006.2.3.281] [PMID: 19412475]
[18]
Mottaghi, A.; Salehi, E.; Keshvarz, A.; Sezavar, H.; Saboor-Yaraghi, A-A. The influence of vitamin A supplementation on Foxp3 and TGF-β gene expression in atherosclerotic patients. J. Nutrigenet. Nutrigenomics, 2012, 5(6), 314-326.
[http://dx.doi.org/10.1159/000341916] [PMID: 23363776]
[19]
Gerring, Z.F.; Powell, J.E.; Montgomery, G.W.; Nyholt, D.R. Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways. Cephalalgia, 2017, 38(2), 292-303.
[http://dx.doi.org/10.1177/0333102416686769] [PMID: 28058943]
[20]
Levy, D. Migraine pain and nociceptor activation-where do we stand? Headache, 2010, 50(5), 909-916.
[http://dx.doi.org/10.1111/j.1526-4610.2010.01670.x] [PMID: 20546325]
[21]
Stoll, G.; Jander, S.; Schroeter, M. Cytokines in CNS disorders: neurotoxicity versus neuroprotection. Advances in Dementia Research; Springer, 2000, pp. 81-89.
[22]
Capers, T. Pathophysiology of Migraine., https://digitalcommons.otterbein.edu/stu_msn/46/ (Accessed 2014).
[23]
Samad, T.A.; Moore, K.A.; Sapirstein, A.; Billet, S.; Allchorne, A.; Poole, S.; Bonventre, J.V.; Woolf, C.J. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature, 2001, 410(6827), 471-475.
[http://dx.doi.org/10.1038/35068566] [PMID: 11260714]
[24]
Takeda, M.; Kitagawa, J.; Takahashi, M.; Matsumoto, S. Activation of interleukin-1β receptor suppresses the voltage-gated potassium currents in the small-diameter trigeminal ganglion neurons following peripheral inflammation. Pain, 2008, 139(3), 594-602.
[http://dx.doi.org/10.1016/j.pain.2008.06.015] [PMID: 18694623]
[25]
Boćkowski, L.; Śmigielska-Kuzia, J.; Sobaniec, W.; Żelazowska-Rutkowska, B.; Kułak, W.; Sendrowski, K. Anti-inflammatory plasma cytokines in children and adolescents with migraine headaches. Pharmacol. Rep., 2010, 62(2), 287-291.
[http://dx.doi.org/10.1016/S1734-1140(10)70268-1] [PMID: 20508283]
[26]
Tanure, M.T.A.; Gomez, R.S.; Hurtado, R.C.L.; Teixeira, A.L.; Domingues, R.B. Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J. Headache Pain, 2010, 11(5), 427-430.
[http://dx.doi.org/10.1007/s10194-010-0233-0] [PMID: 20556464]
[27]
Mirza, M.; Volz, C.; Karlstetter, M.; Langiu, M.; Somogyi, A.; Ruonala, M.O.; Tamm, E.R.; Jägle, H.; Langmann, T. Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation. PLoS One, 2013, 8(10)e75963
[http://dx.doi.org/10.1371/journal.pone.0075963] [PMID: 24124525]
[28]
Thota, R.N.; Acharya, S.H.; Abbott, K.A.; Garg, M.L. Curcumin and long-chain omega-3 polyunsaturated fatty acids for Prevention of type 2 Diabetes (COP-D): study protocol for a randomised controlled trial. Trials, 2016, 17(1), 565.
[http://dx.doi.org/10.1186/s13063-016-1702-9] [PMID: 27894336]
[29]
Jia, Q.; Ivanov, I.; Zlatev, Z.Z.; Alaniz, R.C.; Weeks, B.R.; Callaway, E.S.; Goldsby, J.S.; Davidson, L.A.; Fan, Y.Y.; Zhou, L.; Lupton, J.R.; McMurray, D.N.; Chapkin, R.S. Dietary fish oil and curcumin combine to modulate colonic cytokinetics and gene expression in dextran sodium sulphate-treated mice. Br. J. Nutr., 2011, 106(4), 519-529.
[http://dx.doi.org/10.1017/S0007114511000390] [PMID: 21401974]
[30]
Gescher, A.J. Dose escalation and pharmacokinetic study of nanoparticle curcumin… by Kanai et al., CCP 69:65-70, 2012. Cancer Chemother. Pharmacol., 2012, 70(3), 487.
[http://dx.doi.org/10.1007/s00280-012-1927-6] [PMID: 22810806]
[31]
Sasaki, H.; Sunagawa, Y.; Takahashi, K.; Imaizumi, A.; Fukuda, H.; Hashimoto, T.; Wada, H.; Katanasaka, Y.; Kakeya, H.; Fujita, M.; Hasegawa, K.; Morimoto, T. Innovative preparation of curcumin for improved oral bioavailability. Biol. Pharm. Bull., 2011, 34(5), 660-665.
[http://dx.doi.org/10.1248/bpb.34.660] [PMID: 21532153]
[32]
de Alcântara, G.F.T.; Simões-Neto, E.; da Cruz, G.M.P.; Nobre, M.E.P.; Neves, K.R.T.; de Andrade, G.M.; Brito, G.A.; Viana, G.S. Curcumin reverses neurochemical, histological and immuno-histochemical alterations in the model of global brain ischemia. J. Tradit. Complement. Med., 2016, 7(1), 14-23.
[http://dx.doi.org/10.1016/j.jtcme.2015.10.001] [PMID: 28053883]
[33]
Xu, Z-Z.; Zhang, L.; Liu, T.; Park, J.Y.; Berta, T.; Yang, R.; Serhan, C.N.; Ji, R.R. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat. Med., 2010, 16(5), 592-597. 1p, 597
[http://dx.doi.org/10.1038/nm.2123] [PMID: 20383154]
[34]
Ramirez-Ramirez, V.; Macias-Islas, M.; Ortiz, G.G.; Pacheco-Moises, F.; Torres-Sanchez, E.; Sorto-Gomez, T. Efficacy of fish oil on serum of TNFα, IL-1β, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b. Oxid. Med. Cell. Longev., 2013, 2013
[http://dx.doi.org/10.1155/2013/709493] [PMID: 23861993]
[35]
Ganjali, S.; Sahebkar, A.; Mahdipour, E.; Jamialahmadi, K.; Torabi, S.; Akhlaghi, S. Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. Sci. World J., 2014, 2014898361
[http://dx.doi.org/10.1155/2014/898361]
[36]
Pradalier, A.; Bakouche, P.; Baudesson, G.; Delage, A.; Cornaille-Lafage, G.; Launay, J.M.; Biason, P. Failure of omega-3 polyunsaturated fatty acids in prevention of migraine: a double-blind study versus placebo. Cephalalgia, 2001, 21(8), 818-822.
[http://dx.doi.org/10.1046/j.1468-2982.2001.218240.x] [PMID: 11737007]
[37]
Ji, R-R.; Xu, Z-Z.; Strichartz, G.; Serhan, C.N. Emerging roles of resolvins in the resolution of inflammation and pain. Trends Neurosci., 2011, 34(11), 599-609.
[http://dx.doi.org/10.1016/j.tins.2011.08.005] [PMID: 21963090]
[38]
Shishodia, S. Molecular mechanisms of curcumin action: gene expression. Biofactors, 2013, 39(1), 37-55.
[http://dx.doi.org/10.1002/biof.1041] [PMID: 22996381]
[39]
Takeda, M.; Takahashi, M.; Matsumoto, S. Contribution of activated interleukin receptors in trigeminal ganglion neurons to hyperalgesia via satellite glial interleukin-1beta paracrine mechanism. Brain Behav. Immun., 2008, 22(7), 1016-1023.
[http://dx.doi.org/10.1016/j.bbi.2008.03.004] [PMID: 18440198]

Rights & Permissions Print Cite
Article Metrics
10
1
© 2024 Bentham Science Publishers | Privacy Policy